Brooklyn Immunotherapeutics Inc BTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/27/22 EDT
0.64quote price arrow down-0.03 (-4.88%)
Volume
17,453
Close
0.6728quote price arrow up+0.0428 (+6.79%)
Volume
672,101
52 week range
0.59 - 23.34
Loading...
  • Open0.63
  • Day High0.686
  • Day Low0.62
  • Prev Close0.63
  • 52 Week High23.34
  • 52 Week High Date06/28/21
  • 52 Week Low0.59
  • 52 Week Low Date05/25/22

Key Stats

  • Market Cap38.65M
  • Shares Out57.45M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta4.98
  • YTD % Change-83.87

KEY STATS

  • Open0.63
  • Day High0.686
  • Day Low0.62
  • Prev Close0.63
  • 52 Week High23.34
  • 52 Week High Date06/28/21
  • 52 Week Low0.59
  • 52 Week Low Date05/25/22
  • Market Cap38.65M
  • Shares Out57.45M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta4.98
  • YTD % Change-83.87

RATIOS/PROFITABILITY

  • EPS (TTM)-2.74
  • P/E (TTM)-0.25
  • Fwd P/E (NTM)-1.25
  • EBITDA (TTM)-27.132M
  • ROE (TTM)-3,328.49%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)53.79%
  • Net Margin (TTM)-9,662.64%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Brooklyn Immunotherapeutics Inc

There is no recent news for this security.

Profile

MORE
Brooklyn ImmunoTherapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cytokine-based therapies for treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Its lead product candidate, IRX-2, is a cytokine therapy, to treat patients with head and neck cancer. IRX-2 is a mixed, human-derived cytokine product with multiple active constituents including Interleukin-2 (IL2) and other...
Charles Cherington
Independent Chairman of the Board
Howard Federoff M.D., Ph.D.
President, Chief Executive Officer, Director
Sandra Gurrola
Vice President - Finance
Address
140 58Th Street, Building A, Suite 2100
Brooklyn, NY
92009
United States

Top Peers

SYMBOLLASTCHG%CHG
SYRS
Syros Pharmaceuticals Inc
0.7225+0.0104+1.46%
ANGN
Angion Biomedica Corp
1.50+0.18+13.64%
FSTX
F-Star Therapeutics Inc
2.84+0.30+11.81%
LABP
Landos Biopharma Inc
0.72+0.1074+17.53%
CDAK
Codiak BioSciences, Inc.
2.57-0.04-1.53%